MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$8,857K
Net Income
-$113,628K
Net Profit Margin
-1282.92%
EPS
-$1.22
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Collaboration revenue
8,857
6,560
10,876
207,834
Research and development
108,689
95,726
86,599
82,993
General and administrative
22,459
19,378
18,847
16,389
Total operating expenses
131,148
115,104
105,446
99,382
Loss from operations
-122,291
-108,544
-94,570
108,452
Interest income and other income, net
9,839
10,005
11,297
10,792
Net loss
-112,452
-98,539
-83,273
119,244
Unrealized (losses) gains on marketable securities
-1,176
-2,761
215
531
Comprehensive loss
-113,628
-101,300
-83,058
119,775
Basic EPS
-1.22
-1.11
-0.938
1.35
Diluted EPS
-1.22
-1.11
-0.95
1.33
Basic Average Shares
92,061,452
88,699,754
88,585,639
88,526,781
Diluted Average Shares
92,061,452
88,699,754
87,421,542
89,690,878
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$113,628K
(-46.51%↓ Y/Y)
Net loss
-$112,452K
(-45.12%↓ Y/Y)
Unrealized (losses) gains
on marketable...
-$1,176K
(-1737.50%↓ Y/Y)
Interest income and other
income, net
$9,839K
(-13.04%↓ Y/Y)
Loss from operations
-$122,291K
(-37.71%↓ Y/Y)
Collaboration revenue
$8,857K
Total operating
expenses
$131,148K
(47.68%↑ Y/Y)
Research and development
$108,689K
(46.43%↑ Y/Y)
General and
administrative
$22,459K
(54.04%↑ Y/Y)
Buy us a coffee
IDEAYA Biosciences, Inc. (IDYA)
IDEAYA Biosciences, Inc. (IDYA)